Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the RNA Vaccines industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
BioNTech
CureVac
Moderna Therapeutics
Sangamo Therapeutics
In-Cell-Art
Ethris
Argos Therapeutics
eTheRNA
Tiba Biotechnology
Translate Bio
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
Application:
Infectious Disease
Cancer
Other
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 RNA Vaccines Industry Overview
-
1.1.1 RNA Vaccines Market Scope and Market Segments
-
1.1.2 RNA Vaccines Industry Characteristics
-
1.1.3 Global and China RNA Vaccines Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China RNA Vaccines Production Value and Growth Rate (2017-2028)
-
1.2 Global RNA Vaccines Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Individualized Cancer Treatment MRNA Vaccine
-
1.2.2 Infectious Disease Treatment MRNA Vaccine
-
1.2.3 Infection Prevention MRNA Vaccine
-
1.3 Global RNA Vaccines Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Infectious Disease
-
1.3.2 Cancer
-
1.3.3 Other
-
1.4 Market Analysis by Region
-
1.4.1 North America RNA Vaccines Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe RNA Vaccines Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC RNA Vaccines Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa RNA Vaccines Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global RNA Vaccines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global RNA Vaccines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China RNA Vaccines Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China RNA Vaccines Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global RNA Vaccines Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 RNA Vaccines Industry Porter's Five Forces Model Analysis
-
2.2.3 RNA Vaccines Industry PEST Analysis
-
2.3 RNA Vaccines Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 RNA Vaccines Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on RNA Vaccines Industry
Chapter 3 Global and China RNA Vaccines Market, by Manufacturer
-
3.1 Global and China RNA Vaccines Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China RNA Vaccines Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China RNA Vaccines Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China RNA Vaccines Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China RNA Vaccines Market Top 3 Players
Chapter 4 Global and China RNA Vaccines Market, by Type (2017-2028)
-
4.1 RNA Vaccines Market Trend, by Type
-
4.2 Global RNA Vaccines Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global RNA Vaccines Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global RNA Vaccines Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global RNA Vaccines Price Trend, by Type (2017-2028)
-
4.3 China RNA Vaccines Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China RNA Vaccines Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China RNA Vaccines Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China RNA Vaccines Price Trend, by Type (2017-2028)
Chapter 5 Global and China RNA Vaccines Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global RNA Vaccines Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global RNA Vaccines Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global RNA Vaccines Sales Value and Market Share, by Application (2017-2028)
-
5.3 China RNA Vaccines Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China RNA Vaccines Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China RNA Vaccines Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global RNA Vaccines Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China RNA Vaccines Production, Import, Consumption and Export (2017-2022)
-
6.2 North America RNA Vaccines Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe RNA Vaccines Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC RNA Vaccines Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa RNA Vaccines Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America RNA Vaccines Market Analysis
-
7.1 North America RNA Vaccines Market, by Type
-
7.2 North America RNA Vaccines Market, by Application
-
7.3 North America RNA Vaccines Market Analysis and Forecast, by Country
-
7.3.1 United States RNA Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada RNA Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico RNA Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe RNA Vaccines Market Analysis
-
8.1 Europe RNA Vaccines Market, by Type
-
8.2 Europe RNA Vaccines Market, by Application
-
8.3 Europe RNA Vaccines Market Analysis and Forecast, by Country
-
8.3.1 Germany RNA Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK RNA Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France RNA Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy RNA Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries RNA Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain RNA Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium RNA Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland RNA Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia RNA Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey RNA Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC RNA Vaccines Market Analysis
-
9.1 APAC RNA Vaccines Market, by Type
-
9.2 APAC RNA Vaccines Market, by Application
-
9.3 APAC RNA Vaccines Market Analysis and Forecast, by Country
-
9.3.1 China RNA Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan RNA Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand RNA Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India RNA Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries RNA Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea RNA Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa RNA Vaccines Market Analysis
-
10.1 Latin America, Middle East and Africa RNA Vaccines Market, by Type
-
10.2 Latin America, Middle East and Africa RNA Vaccines Market, by Application
-
10.3 Latin America, Middle East and Africa RNA Vaccines Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries RNA Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil RNA Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria RNA Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa RNA Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina RNA Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China RNA Vaccines Company Profiles
-
11.1 BioNTech
-
11.1.1 BioNTech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 BioNTech RNA Vaccines Product Profiles, Application and Specification
-
11.1.3 BioNTech RNA Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 CureVac
-
11.2.1 CureVac Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 CureVac RNA Vaccines Product Profiles, Application and Specification
-
11.2.3 CureVac RNA Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Moderna Therapeutics
-
11.3.1 Moderna Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Moderna Therapeutics RNA Vaccines Product Profiles, Application and Specification
-
11.3.3 Moderna Therapeutics RNA Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Sangamo Therapeutics
-
11.4.1 Sangamo Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Sangamo Therapeutics RNA Vaccines Product Profiles, Application and Specification
-
11.4.3 Sangamo Therapeutics RNA Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 In-Cell-Art
-
11.5.1 In-Cell-Art Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 In-Cell-Art RNA Vaccines Product Profiles, Application and Specification
-
11.5.3 In-Cell-Art RNA Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Ethris
-
11.6.1 Ethris Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Ethris RNA Vaccines Product Profiles, Application and Specification
-
11.6.3 Ethris RNA Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Argos Therapeutics
-
11.7.1 Argos Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Argos Therapeutics RNA Vaccines Product Profiles, Application and Specification
-
11.7.3 Argos Therapeutics RNA Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 eTheRNA
-
11.8.1 eTheRNA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 eTheRNA RNA Vaccines Product Profiles, Application and Specification
-
11.8.3 eTheRNA RNA Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Tiba Biotechnology
-
11.9.1 Tiba Biotechnology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Tiba Biotechnology RNA Vaccines Product Profiles, Application and Specification
-
11.9.3 Tiba Biotechnology RNA Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Translate Bio
-
11.10.1 Translate Bio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Translate Bio RNA Vaccines Product Profiles, Application and Specification
-
11.10.3 Translate Bio RNA Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 RNA Vaccines Industry Investment Prospect and Risk Assessment
-
12.1 RNA Vaccines Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 RNA Vaccines Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global RNA Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure China RNA Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Global RNA Vaccines Production Value and Growth Rate (2017-2028)
-
Figure China RNA Vaccines Production Value and Growth Rate (2017-2028)
-
Figure Global RNA Vaccines Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine (2017-2028)
-
Figure Global RNA Vaccines Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine (2017-2028)
-
Figure Global RNA Vaccines Market Size and Growth Rate of Infection Prevention MRNA Vaccine (2017-2028)
-
Figure Global RNA Vaccines Market Size and Growth Rate of Infectious Disease (2017-2028)
-
Figure Global RNA Vaccines Market Size and Growth Rate of Cancer (2017-2028)
-
Figure Global RNA Vaccines Market Size and Growth Rate of Other (2017-2028)
-
Figure North America RNA Vaccines Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe RNA Vaccines Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC RNA Vaccines Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa RNA Vaccines Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global RNA Vaccines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China RNA Vaccines Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China RNA Vaccines Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China RNA Vaccines Sales Value, by Manufacturer (2021&2022)
-
Table Global and China RNA Vaccines Market Share, by Manufacturer (2021&2022)
-
Figure Global and China RNA Vaccines Market Share, by Manufacturer in 2021
-
Figure Global and China RNA Vaccines Market Share, by Manufacturer in 2022
-
Table Global RNA Vaccines Sales Volume, by Type (2017-2028)
-
Table Global RNA Vaccines Sales Volume Share, by Type (2017-2028)
-
Figure Global RNA Vaccines Sales Volume Share, by Type (2017-2028)
-
Table Global RNA Vaccines Sales Value, by Type (2017-2028)
-
Table Global RNA Vaccines Sales Value Share, by Type (2017-2028)
-
Figure Global RNA Vaccines Price Trend, by Type (2017-2028)
-
Table China RNA Vaccines Sales Volume, by Type (2017-2028)
-
Table China RNA Vaccines Sales Volume Share, by Type (2017-2028)
-
Figure China RNA Vaccines Sales Volume Share, by Type (2017-2028)
-
Table China RNA Vaccines Sales Value, by Type (2017-2028)
-
Table China RNA Vaccines Sales Value Share, by Type (2017-2028)
-
Figure China RNA Vaccines Price Trend, by Type (2017-2028)
-
Table Global RNA Vaccines Sales Volume, by Application (2017-2028)
-
Table Global RNA Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure Global RNA Vaccines Sales Volume Share, by Application (2017-2028)
-
Table Global RNA Vaccines Sales Value, by Application (2017-2028)
-
Table Global RNA Vaccines Sales Value Share, by Application (2017-2028)
-
Figure Global RNA Vaccines Sales Value Share, by Application (2017-2028)
-
Table China RNA Vaccines Sales Volume, by Application (2017-2028)
-
Table China RNA Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure China RNA Vaccines Sales Volume Share, by Application (2017-2028)
-
Table China RNA Vaccines Sales Value, by Application (2017-2028)
-
Table China RNA Vaccines Sales Value Share, by Application (2017-2028)
-
Figure China RNA Vaccines Sales Value Share, by Application (2017-2028)
-
Figure China RNA Vaccines Production, Import, Consumption and Export (2017-2022)
-
Figure North America RNA Vaccines Production, Import, Consumption and Export (2017-2022)
-
Figure Europe RNA Vaccines Production, Import, Consumption and Export (2017-2022)
-
Figure APAC RNA Vaccines Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa RNA Vaccines Production, Import, Consumption and Export (2017-2022)
-
Table North America RNA Vaccines Sales Volume, by Type (2017-2028)
-
Table North America RNA Vaccines Sales Volume Share, by Type (2017-2028)
-
Figure North America RNA Vaccines Sales Volume Share, by Type (2017-2028)
-
Table North America RNA Vaccines Sales Volume, by Application (2017-2028)
-
Table North America RNA Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure North America RNA Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure United States RNA Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure United States RNA Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Canada RNA Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Canada RNA Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Mexico RNA Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico RNA Vaccines Sales Value and Growth Rate (2017-2028)
-
Table Europe RNA Vaccines Sales Volume, by Type (2017-2028)
-
Table Europe RNA Vaccines Sales Volume Share, by Type (2017-2028)
-
Figure Europe RNA Vaccines Sales Volume Share, by Type (2017-2028)
-
Table Europe RNA Vaccines Sales Volume, by Application (2017-2028)
-
Table Europe RNA Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure Europe RNA Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure Germany RNA Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Germany RNA Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure UK RNA Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure UK RNA Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure France RNA Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure France RNA Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Italy RNA Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Italy RNA Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries RNA Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries RNA Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Spain RNA Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Spain RNA Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Belgium RNA Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium RNA Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Poland RNA Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Poland RNA Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Russia RNA Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Russia RNA Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Turkey RNA Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey RNA Vaccines Sales Value and Growth Rate (2017-2028)
-
Table APAC RNA Vaccines Sales Volume, by Type (2017-2028)
-
Table APAC RNA Vaccines Sales Volume Share, by Type (2017-2028)
-
Figure APAC RNA Vaccines Sales Volume Share, by Type (2017-2028)
-
Table APAC RNA Vaccines Sales Volume, by Application (2017-2028)
-
Table APAC RNA Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure APAC RNA Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure China RNA Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure China RNA Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Japan RNA Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Japan RNA Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand RNA Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand RNA Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure India RNA Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure India RNA Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries RNA Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries RNA Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure South Korea RNA Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea RNA Vaccines Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa RNA Vaccines Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa RNA Vaccines Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa RNA Vaccines Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa RNA Vaccines Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa RNA Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa RNA Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries RNA Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries RNA Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Brazil RNA Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil RNA Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria RNA Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria RNA Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure South Africa RNA Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa RNA Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Argentina RNA Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina RNA Vaccines Sales Value and Growth Rate (2017-2028)
-
Table BioNTech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table BioNTech Product Profiles, Application and Specification
-
Table BioNTech RNA Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table CureVac Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table CureVac Product Profiles, Application and Specification
-
Table CureVac RNA Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Moderna Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Moderna Therapeutics Product Profiles, Application and Specification
-
Table Moderna Therapeutics RNA Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sangamo Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sangamo Therapeutics Product Profiles, Application and Specification
-
Table Sangamo Therapeutics RNA Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table In-Cell-Art Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table In-Cell-Art Product Profiles, Application and Specification
-
Table In-Cell-Art RNA Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Ethris Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Ethris Product Profiles, Application and Specification
-
Table Ethris RNA Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Argos Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Argos Therapeutics Product Profiles, Application and Specification
-
Table Argos Therapeutics RNA Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table eTheRNA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table eTheRNA Product Profiles, Application and Specification
-
Table eTheRNA RNA Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Tiba Biotechnology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Tiba Biotechnology Product Profiles, Application and Specification
-
Table Tiba Biotechnology RNA Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Translate Bio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Translate Bio Product Profiles, Application and Specification
-
Table Translate Bio RNA Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
